OLPHARM LLC is an independent accredited laboratory and research center. As CRO we are aim to simplify entry into Russian and CIS markets of drug, fud supplements and medical devices.
The scope of accreditation includes a wide range of physico-chemical, microbiological, virological and biological methods.
The testing laboratory is accredited to confirm the conformity of medicines: biological, immunobiological, homeopathic, for veterinary use, substances, excipients, etc.
The capabilities of the research center allow the wide range of drug research: safety and efficacy studies, stability tests, development and validation of MoA, etc.
The R&D center of OLPHARM was founded in 2006 on the basis of the State Scientific Center for Antibiotics which technical and personnel potential was used.
In 2019, a large-scale reconstruction of new sites for the OLPHARM testing laboratory took place. The new buildings with a total area of 2000 m2, are located on the territory of the IQ-Park business district.
In 2020, the Declaration of Compliance of the laboratory with the requirements of GOST ISO/IEC17025-2019 "General requirements for the competence of testing and calibration laboratories" was adopted.
The presence of a team of professionals, rich experience, modern equipment, the availability of facilities modernized to meet the requirements of GLP ensures high quality and reliability of research at OLPHARM.
For many years, our partners and customers have been pharmaceutical companies and research organizations located on the territory of the Russia, India, Slovenia and Belorussia.
